Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome

Quality of Life Research

Volumn 8, Issue 1-2, 1999, Pages 9-16

  Myers, C ^a   Wilks, D ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Chronic fatigue syndrome; Euroqol EQ 5D; SF 36

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DISABILITY; FEMALE; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; DISABLED PERSONS; DISCRIMINANT ANALYSIS; FATIGUE SYNDROME, CHRONIC; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCOTLAND; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0032774309     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026459027453     Document Type: Article

References (14)

1. 1. Sharpe MC, Archard LC, Banatvala JE et al. A report-chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118-121.
2. 2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121: 953-959.
3. 3. Garrat AM, Ruta DA, Abdalla MI, Buckingham JK, Russel IT. The SF-36 health survey questionnaire : an outcome measure suitable for routine use within the NHS? BMJ 1993; 306: 1440-1444.
4. 4. Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W. Functional status in patients with CFS, other fatiguing illnesses and healthy individuals. Am J Med 1996; 101(4): 364-370.
5. 5. Komaroff AL, Fagioli LR, Doolittle TH et al. Health status in patients with CFS and in general population and disease comparison groups. Am J Med 1996; 101(3): 281-290.
6. 6. The Euroqol Group. Euroqol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
7. 7. Anonymous. Euroqol EQ-5D User Guide, Version A: 1-12.
8. 8. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998; 316: 736-741.
9. 9. Hurst NP, Jobanputra P, Hunter M, Lambert M, Lochhead A, Brown M. Validity of Euroqol - a generic health status instrument - in patients with rheumatoid arthritis. Br J Rheumatol 1994; 33: 655-662.
10. 10. Brazier JE, Walters SJ, Nicholl JP, Kohler B. Using the SF-36 and Euroqol on an elderly population. Qual Life Res 1996; 5(2): 195-204.
11. 11. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993; 2: 169-180.
12. 12. Ware JE, Snow KK, Kosinski M, Gandek B. Scoring the SF-36. In: SF-36 Health Survey Manual & Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
13. 13. Jenkinson C, Coulter A, Wright L. Short form 36 (SF 36) health survey questionnaire: normative data for adults of working age. BMJ 1993; 306: 1437-1440.
14. 14. Manu P, Affleck G, Tennen H, Morse PA, Escobar JI. Hypochondriasis influences quality-of-life outcomes in patients with chronic fatigue. Psychother Psychosomat 1996; 65(2): 76-81.